Business Wire

Green Street Acquires IJGlobal, Leading Provider of Global Infrastructure Data, News and Events

5.9.2024 13:02:00 CEST | Business Wire | Press release

Share

--Green Street Continues to Grow, Expanding Its Global Product Suite with Comprehensive and Granular Property-Level Data, News and Events in Infrastructure--

Green Street, the preeminent provider of commercial real estate intelligence and analytics in the U.S., Canada, and Europe, has acquired IJGlobal, part of the Delinian Group – leading provider of data, news, and events covering all aspects of the international infrastructure and energy finance industry. IJGlobal is Green Street’s fifth acquisition since 2020, and it follows the May 2024 acquisition of Locatus – a Netherlands based provider of independently sourced retail data and analytics in the Benelux region.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240905220824/en/

Green Street, the leading provider of Commercial Real Estate intelligence, acquires IJGlobal, a comprehensive infrastructure company that includes a data platform, global news, and industry leading events/awards. (Graphic: Business Wire)

“IJGlobal is committed to being the market’s most comprehensive source of infrastructure intelligence with a global presence across North America, South America, Asia, Africa, Europe, and Australia, and its great talent and reputation for providing top-quality objective insights make a strong fit for Green Street. IJGlobal’s deep coverage of infrastructure accelerates our commitment to expanding property-level data and analytics across sectors and geographies and dramatically strengthens our increasing coverage of the infrastructure sector on a global basis,” said Jeffry Stuek Jr., Green Street’s Chief Executive Officer. “We are excited to integrate these capabilities to provide our clients with industry leading insight.”

For more than 17 years, IJGlobal has been delivering the market’s most comprehensive infrastructure intelligence through a database of 55,000+ transactions, 41,000+ assets, and 3,400+ funds. Their team of experts publishes more than 40 stories a day to inform financial structure, policy, pricing, and key market players, helping customers manage risk and identify leads. They also track and celebrate key infrastructure and energy industry achievements through a multitude of annual Events and Awards that connect the market and accelerate deals. IJGlobal services a wide range of customer segments including financial advisers and lenders, legal advisers, Development Finance Institutions (DFIs), institutional investors, project sponsors, and infrastructure funds, among others.

Commenting on the sale, Andrew Pinder, Chief Executive Officer of Delinian, said, “In line with our continued strategy of ‘invest, grow and divest’ for each of our portfolio companies, we are delighted that Green Street represents such a great fit for IJGlobal. It offers the business an exciting opportunity to further expand its depth and reach of infrastructure insights, data and events, with access to resources and expertise within a broader property-level data and analytics ecosystem. We wish the IJGlobal team every success as they now transition to Green Street.”

For more information, visit the IJGlobal website or Green Street website.

About Green Street

Green Street is the preeminent provider of actionable commercial real estate research, news, data, analytics, and advisory services in the U.S., Canada, and Europe. For nearly 40 years, Green Street has delivered unparalleled intelligence and trusted data on the public and private real estate markets, helping investors, banks, lenders, and other industry participants optimize investment and strategic decisions. The firm delivers exclusive market information, conclusion-driven insights, and predictive analytics through a SaaS platform. To learn more, please visit https://www.greenstreet.com.

About IJGlobal

IJGlobal is a single source of data, intelligence and analysis covering all aspects of the international infrastructure and energy finance industry. IJGlobal delivers news, transaction and investor/fund data, and events for global infrastructure to market participants worldwide, and through a comprehensive database that encompasses all infrastructure transaction participants, exclusive daily news, live League Table rankings, and more. IJGlobal is headquartered in London and was founded in 1997. For more information, please visit https://hub.ijglobal.com/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240905220824/en/

Contacts

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing5.2.2026 07:30:00 CET | Press release

Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato-ku, Tokyo; Chairman, President and Group CEO: Shigekazu Takeuchi) and Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano, “Sysmex”) have agreed on a sales collaboration for dementia testing. This agreement follows continued discussions based on the Basic Agreement on Business Collaboration in the Field of Immunoassay concluded in October 2023.1 Sysmex will exclusively sell Fujirebio's fully automated Lumipulse® immunoassay systems and dementia-related reagents ("the Products") in regions and countries mutually agreed upon by both companies. Going forward, Fujirebio and Sysmex will collaborate to meet the growing testing needs accompanying the wider adoption of therapeutic drugs and will gradually expand the countries where the Products are sold. Since entering into the Basic Agreement on Business Collaboration in Octob

Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide5.2.2026 06:30:00 CET | Press release

Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat®KMT2A + MRD Assay and Software to its industry-leading oncology portfolio. The assay leverages digital PCR (dPCR) to support both screening and precise longitudinal MRD monitoring for KMT2A rearrangements in acute myeloid leukemia (AML) subjects. This quantitative test is currently available for research use in clinical trials and as a stand-alone kit for purchase by our global customers, and will soon be available as a service in our regional LabPMM® laboratories worldwide. The assay is available to detect key AML-associated KMT2A rearrangements, which account for the vast majority of KMT2A fusion partners in AML1 and those most commonly targeted in menin-inhibitor clinical development programs. Later this year, the assay will be enhanced with four additional KMT2A rearrangements which are frequently found in acute lymphocytic leukemia (ALL), expan

VeriSilicon Enhanced ISP8200-FS Series IP Achieves ASIL B Functional Safety Certification5.2.2026 01:00:00 CET | Press release

Enabling Next-Generation High-Performance Automotive Camera Systems VeriSilicon (688521.SH) today announced its latest enhanced versions of Image Signal Processing (ISP) IP ISP8200-FS series, ISP8200-ES and ISP8200L-ES, featuring improved performance and energy efficiency to better support complex automotive camera systems. These enhanced IPs have successfully achieved ISO 26262 ASIL B functional safety certifications issued by TÜV NORD, an international inspection and certification institution, further validating their suitability and reliability for ADAS and autonomous driving applications. The latest enhanced ISP8200-FS series IP can operate at up to 1.2 GHz and support data processing from up to 16 image sensors. It significantly improves the performance of multi-camera scheduling, enabling flexible data-access capabilities and efficient hardware pipeline utilization for automotive camera systems. The enhanced series IP integrates image processing technologies including Color Noise

Kinaxis Inc. to Host Fourth Quarter 2025 Financial Results Conference Call on March 5, 20264.2.2026 22:30:00 CET | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its fourth quarter and year ended December 31, 2025. The call will be hosted on Thursday, March 5 at 8:30 a.m. Eastern Time by Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the fourth quarter and year after the close of markets on Wednesday, March 4, 2026. CONFERENCE CALL DETAILS DATE: Thursday, March 5, 2026 TIME: 8:30 a.m. Eastern Time WEBCAST: https://events.q4inc.com/attendee/567578009 (available for three months) About Kinaxis Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that

Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 22:30:00 CET | Press release

Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye